Introduction: Parkinson's disease is an idiopathic, slow progressive neurodegenerative condition with the loss of dopaminergic neurons in the substantia nigra compacta of the midbrain. Due to cardiovascular dysautonomia and impaired baroreflex function in Parkinson's disease, the development of orthostatic hypotension is most common, along with increased blood pressure variability, supine hypertension, nocturnal hypertension, etc. Orthostatic hypotension in Parkinson's disease increases the risk of developing coronary heart disease, myocardial infarction, and the risk of overall, and cardiovascular mortality. Case report: Orthostatic hypotension in Parkinson's disease is associated with an increased risk of gait disturbances, loss of balance, falls resulting in injuries and limb fractures, and mortality. In this paper, we presented a patient who had previously been treated for arterial hypertension, with the current clinical presentation of symptomatic orthostatic hypotension in Parkinson's disease. After neurological evaluation and the implementation of pharmacological and non-pharmacological therapy for orthostatic hypotension, gradual improvement and stabilization of blood pressure values are achieved, along with a reduction in orthostatic hypotension symptoms and a decrease in subjective discomfort. Conclusion: In the presence of orthostatic hypotension in Parkinson's disease, in addition to pharmacological therapy, nonpharmacological treatment measures are very important for stabilizing blood pressure values and reducing the symptoms of orthostatic hypotension.
References
1.
Scorza FA, Guimarães-Marques M, Nejm M, de Almeida ACG, Scorza CA, Fiorini AC, et al. Sudden unexpected death in Parkinson’s disease: Insights from clinical practice. Vol. 77, Clinics. 2022. p. 100001.
2.
Bloem BR, Okun MS, Klein C. Parkinson’s disease. Vol. 397, The Lancet. 2021. p. 2284–303.
3.
Brakedal B, Toker L, Haugarvoll K, Tzoulis C. A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population. Vol. 8, npj Parkinson’s Disease.
4.
Park JH, Kim DH, Park YG, Kwon DY, Choi M, Jung JH, et al. Association of Parkinson Disease With Risk of Cardiovascular Disease and All-Cause Mortality. Vol. 141, Circulation. 2020. p. 1205–7.
5.
Hou JGG, Lai EC. Non-motor Symptoms of Parkinson’s Disease. Vol. 1, International Journal of Gerontology. 2007. p. 53–64.
6.
Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment. Vol. 134, Neurobiology of Disease. 2020. p. 104700.
7.
Zhu S, Li H, Xu X, Luo Y, Deng B, Guo X, et al. The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson’s Disease: What We Know and Where to Go. Vol. 12, Aging and disease. 2021. p. 1675.
8.
Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. Vol. 84, Journal of Neurology, Neurosurgery & Psychiatry. 2013. p. 674–80.
9.
Katsi V, Papakonstantinou I, Solomou E, Antonopoulos AS, Vlachopoulos C, Tsioufis K. Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson’s Disease—a Systematic Review. Vol. 23, Current Hypertension Reports. 2021.
10.
Douma LG, Gumz ML. Circadian clock-mediated regulation of blood pressure. Vol. 119, Free Radical Biology and Medicine. 2018. p. 108–14.
11.
Vetrano DL, Pisciotta MS, Brandi V, Lo Monaco MR, Laudisio A, Onder G, et al. Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson’s disease. Vol. 19, The Journal of Clinical Hypertension. 2017. p. 418–23.
12.
Milazzo V, Di Stefano C, Vallelonga F, Sobrero G, Zibetti M, Romagnolo A, et al. Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease. Vol. 56, Parkinsonism & Related Disorders. 2018. p. 82–7.
13.
Sommer S, Aral-Becher B, Jost W. Nondipping in Parkinson’s Disease. Vol. 2011, Parkinson’s Disease. 2011. p. 1–5.
14.
Vallelonga F, Romagnolo A, Merola A, Sobrero G, Di Stefano C, Milazzo V, et al. Detection of orthostatic hypotension with ambulatory blood pressure monitoring in parkinson’s disease. Vol. 42, Hypertension Research. 2019. p. 1552–60.
15.
Stuebner E, Vichayanrat E, Low DA, Mathias CJ, Isenmann S, Haensch CA. Twenty-Four Hour Non-Invasive Ambulatory Blood Pressure and Heart Rate Monitoring in Parkinson’s Disease. Vol. 4, Frontiers in Neurology.
16.
P O, WH J. Orthostatic Hypotension and Parkinson’s Disease: A Review about Epidemiology, Pathophysiology and Clinical Management. Vol. 7. p. 1876.
17.
Fanciulli A, Leys F, Falup-Pecurariu C, Thijs R, Wenning GK. Management of Orthostatic Hypotension in Parkinson’s Disease. Vol. 10, Journal of Parkinson’s Disease. 2020. p. S57–64.
18.
Lamotte G, Lenka A. Orthostatic Hypotension in Parkinson Disease. Vol. 12, Neurology Clinical Practice. 2022.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.